New Publication: Bivalirudin vs Heparin in Pediatric ECMO Meta-Analysis

A new publication on bivalirudin was released on September 16, 2026. Titled "Clinical outcomes of bivalirudin and heparin in pediatric extracorporeal membrane oxygenation: A systematic review and meta-analysis," the study appeared in The International Journal of Artificial Organs. The publication is a systematic review and meta-analysis examining bivalirudin and heparin use in pediatric patients undergoing extracorporeal membrane oxygenation, or ECMO. No specific findings or outcome data from the analysis are included in this brief. Readers interested in the full scope of the comparison, including methodology and reported outcomes, are encouraged to consult the original article directly. Bivalirudin is an approved compound, and this publication represents newly indexed academic literature rather than a regulatory action or clinical trial result. The listing reflects only the fact that this systematic review and meta-analysis has been published, without characterizing its conclusions. For additional background on bivalirudin, including its approved uses and general profile, readers can refer to the compound overview.